Skip to content
★ Sign in to follow
CP

Claire Poll

Board Director
Conseiller Juridique
Verona Pharma plc
Total declarations
39
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (8 ops.)
€1.3M

Latest filing published 05 Feb 2024 for Verona Pharma plc, €220k.

Filing timeline

BuySale
Claire Poll

Insider track record

Disclosed buys
0
Disclosed sells
8

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Claire Poll: trading record in brief

Claire Poll (board member) discloses dealings in Verona Pharma plc to SEC (Form 4). We count 39 filings; the first trade dates from 1 August 2021 and the latest from 1 February 2024.

Every open-market trade on record is a sale: 8 sales worth €1.3M. The rest of the record consists of 9 share grants and 2 option exercises.

Most recently, on 5 February 2024, the filings show a transaction in Verona Pharma plc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Claire Poll

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total
  • ◆
    General CounselExecutivesVerona Pharma plc
    237,197 USD12SEC
    103,408 shares@ US$2.293814.6% of flowOrdinary SharesSEC:0001104659-24-010785:0
  • ◆
    General CounselExecutivesVerona Pharma plc
    303,254 USD13SEC
    173,904 shares@ US$1.743819.1% of flowOrdinary SharesSEC:0001104659-23-114406:0
  • ◆
    General CounselExecutivesVerona Pharma plc
    0SEC
    200,000 shares0Ordinary SharesSEC:0001104659-23-111092:0
  • ▼
    General CounselExecutivesVerona Pharma plc
    52,324 USD29SEC
    20,608 shares@ US$2.5393.2% of flowOrdinary SharesSEC:0001104659-23-088490:0
  • ▼
    General CounselExecutivesVerona Pharma plc
    49,851 USD29SEC
    18,608 shares@ US$2.6793.0% of flowOrdinary SharesSEC:0001104659-23-087443:0
  • ◇
    General CounselExecutivesVerona Pharma plc
    0SEC
    8,328 sharesOrdinary SharesSEC:0001104659-23-059151:0
  • ▼
    General CounselExecutivesVerona Pharma plc
    207,041 USD30SEC
    80,376 shares@ US$2.575912.6% of flowOrdinary SharesSEC:0001104659-23-055649:0
  • ◇
    General CounselExecutivesVerona Pharma plc
    0SEC
    178,800 shares0Ordinary SharesSEC:0001104659-23-010732:0
  • ●
    General CounselExecutivesVerona Pharma plc
    0SEC
    90,104 shares0Ordinary SharesSEC:0001104659-22-130251:0
  • ◆
    General CounselExecutivesVerona Pharma plc
    0SEC
    800,000 shares0Ordinary SharesSEC:0001104659-22-103711:0
  • ◆
    General CounselExecutivesVerona Pharma plc
    53,730 USD11SEC
    79,896 shares@ US$0.67253.5% of flowOrdinary SharesSEC:0001104659-22-085625:0
  • ◆
    General CounselExecutivesVerona Pharma plc
    41,746 USD11SEC
    79,896 shares@ US$0.52253.3% of flowOrdinary SharesSEC:0001104659-22-055449:0
  • ◆
    General CounselExecutivesVerona Pharma plc
    62,023 USD11SEC
    79,896 shares@ US$0.77634.6% of flowOrdinary SharesSEC:0001104659-22-011439:0
  • ◆
    General CounselExecutivesVerona Pharma plc
    51,133 USD11SEC
    79,896 shares@ US$0.643.7% of flowOrdinary SharesSEC:0001104659-21-133856:0
  • ◆
    General CounselExecutivesVerona Pharma plc
    250,886 USD13SEC
    319,600 shares@ US$0.78517.8% of flowOrdinary SharesSEC:0001104659-21-099695:0

15 of 15 declarations